Zdrowie i gospodarka · 16/04/2018
FDA Announces Draft Guidance for Streamlined In Vitro Diagnostic Submission Process in Oncology Trials
The FDA has released a draft guidance outlining an optional streamlined process for determining the risk of investigational in vitro diagnostics in oncology clinical trials, allowing for more efficient review and submission of study data.